Akincilar SC et al. (2022)
Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer.
Shin, E.M. et al. (2021)
GREB1 : An evolutionarily conserved protein with a glycosyltransferase domain links ERa glycosylation and stability to cancer.
Akincilar SC et al. (2020)
NAIL: an evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitis.
Cildir G et al. (2019)
Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases.
Akıncılar SC et al. (2016)
Long-range chromatin interactions drive mutant Tert promoter activation.
Khattar E, Kumar et al. (2016)
Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.
Li Y et al. (2015)
Non-canonical NFkB signaling and ETS1/2 cooperatively drive mutant TERT promoter activation.
Koh CM et al. (2015)
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Ghosh A et al. (2012)
Telomerase directly regulates NFκB dependent transcription.
Wu Z et al. (2010)
ATM and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress.
Teo H et al. (2010)
Telomere independent Rap1 is an IKK-adaptor and regulates NFΚB-dependent gene expression.
Chew J et al. (2009)
WIP1 phosphatase is a negative regulator of NF-kappaB signalling.